News
Tramway Venture Partners
Tramway Ventures awarded Early-Stage VC Firm of the Year by MedTech World North America 2026
Tue, 12 May 2026 More than 5,000 public votes, combined with the insights of an independent steering committee, helped determine the winners of the awards presented during Day 0 of…
How The BioScience Center is helping New Mexico’s tech industry thrive
Technology continues to advance extremely quickly across the globe, and that is no different here in New Mexico. Some of the major growth that the Land of Enchantment is seeing…
Tramway Ventures lands state boost for new $40M fund
By Jacob Maranda – New Mexico Inno Reporter September 19, 2023, 05:12pm MDT There could soon be a lot more venture capital flowing into New Mexico companies thanks to…
Armonica Technologies
Armonica Announces Appointment of Emily Milsovic as CEO
CARLSBAD, Calif., May 29, 2024 /PRNewswire/ — Armonica, a pioneer in optical epigenetic sequencing has appointed Emily Milsovic as its new chief executive officer (CEO), effective immediately. Ms. Milsovic succeeds…
Armonica Technologies announces Todd Dickinson joins Board of Directors
SAN DIEGO, March 13, 2024 /PRNewswire/ — Armonica Technologies, Inc., a pioneer in sample-prep free direct optical DNA sequencing, today announced the appointment of life science leader Todd Dickinson to the…
Armonica Technologies announces Emily Milsovic joins Board of Directors
SAN DIEGO, Feb. 26, 2024 /PRNewswire/ — Armonica Technologies, Inc., a pioneer in sample-prep free direct optical DNA sequencing, today announced the appointment of biotech veteran Emily Milsovic to the Board…
BennuBio
BennuBio Inc. Receives $1 Million Grant For Novel Biological Screening Technology Development
BennuBio was awarded an NIH (National Institute of Health) SBIR (Small Business Innovation Research) grant that will advance the Company’s development of a novel analytic tool for 3D tissue models….
Flow Cytometry Startup BennuBio Secures $5M in Series B Funding Round
NEW YORK – Flow cytometry startup BennuBio has closed on $5 million of a $7 million Series B financing round, which it plans to use to expand commercial efforts, accelerate…
- « Previous
- 1
- 2
- 3
Circular Genomics
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Circular Genomics for the Transformative Bio-Hermes-001 Study
Washington D.C., May 28, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Circular Genomics, a biotechnology company revolutionizing neurological and psychiatric precision medicine,…
Circular Genomics and Vitazi.ai Forge Strategic Alliance to Develop First-in-Class Multimodal Workflow for Early Alzheimer’s Detection
SAN DIEGO, April 29, 2026 /PRNewswire/ — Circular Genomics, the precision neurology leader pioneering circular RNA (circRNA)-based molecular diagnostics, today announced a strategic alliance with Vitazi.ai, an innovator in AI-powered…
Circular Genomics Strengthens Scientific Advisory Board with the Addition of Esteemed Alzheimer’s Experts
Michael Weiner, MD and Timothy Hohman, PhD, bring decades of experience in neurological diseases with a focus on Alzheimer’s disease SAN DIEGO, Dec. 8, 2025 /PRNewswire/ — Circular Genomics, a…
WaveDyn Vision
Senior Ophthalmology Executive Thomas A. (Tom) Dunlap Joins WaveFront Dynamics Inc. as an Independent Member of the Board of Directors to Support the Company’s Ongoing Commercialization and Broader Strategic Initiatives
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WDI), a venture backed company and pioneer in wavefront sensing technology for use in measuring and perfecting visual performance, today announced the appointment of Tom…
WaveFront Dynamics Inc. Launches WaveDȳn® Vision Analyzer
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc., an ophthalmic medical device company, announced today the commercial launch of its dynamic aberrometry measurement system, the WaveDyn Vision Analyzer. The WaveDyn Vision Analyzer (pronounced…
WaveFront Dynamics Inc. Initiates $3mm Series A Round to Fund Continued Development of Dynamic Wavefront Measurement System for Vision Correction
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WaveDyn™), an early stage ophthalmic medical device company, today announced the first close of a $3 million Series A financing round. The round was led by…
Vitazi.ai
Circular Genomics and Vitazi.ai Forge Strategic Alliance to Develop First-in-Class Multimodal Workflow for Early Alzheimer’s Detection
SAN DIEGO, April 29, 2026 /PRNewswire/ — Circular Genomics, the precision neurology leader pioneering circular RNA (circRNA)-based molecular diagnostics, today announced a strategic alliance with Vitazi.ai, an innovator in AI-powered…
VSP Vision Innovation Challenge Winners Revealed at Vision Expo West 2025
LAS VEGAS—Vision Expo West, produced by RX and The Vision Council, in collaboration with VSP Vision, a leader in health-focused vision care, and MATTER, the premier health care incubator and…
Vitazi.ai Announces Partnership with Eye Associates of New Mexico to Advance AI-Powered Retinal Screening
SANTA FE, N.M., Feb. 12, 2025 /PRNewswire/ — Vitazi.ai, Inc., a key leader in Oculomics, is pleased to announce an agreement with Eye Associates of New Mexico, the largest ophthalmology…